Biopharmaceuticals
Licensing
News Release - November 6, 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Source: Geron
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.